Home›Antibody-drug conjugates›Brentuksimab vedotin🌐Bahasa IndonesiaEnglishBahasa IndonesiaDeutschFrançaisItalianoNederlandsРусскийالعربية中文日本語EntityQ422324· pop 13· linked from 371 articlesBrentuksimab vedotinAlso known as SGN-35, cAC10-vcMMAE, brentuximab, Adcetrissenyawa kimiaResearch1,832 papersBrentuximab vedotin in T-cell lymphoma.Expert review of hematology · 2019Brentuximab vedotin.mAbs · 2012Brentuximab vedotin.Clinical cancer research : an official journal of the American Association for Cancer Research · 2013Brentuximab vedotin use in pediatric anaplastic large cell lymphoma.Frontiers in immunology · 2023Brentuximab vedotin.Drugs in R&D · 2011via PubMedAvailable in 13 languagesFrançaisDeutsch中文日本語РусскийItalianoالعربيةBahasa IndonesiaOdiaConnectionsfusion proteinEntityHodgkin lymphomaEntityCategoriesAntibody-drug conjugatesChemicals that do not have a ChemSpider ID assignedDrugboxes which contain changes to verified fieldsDrugboxes which contain changes to watched fieldsDrugs developed by Takeda Pharmaceutical CompanyDrugs that are a monoclonal antibodyDrugs with non-standard legal statusInfobox-drug molecular-weight unexpected-characterMonoclonal antibodiesOrphan drugsSource attribution